HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$6.61
Day range
$6.45 - $6.92
Year range
$3.67 - $13.50
Market cap
648.26M USD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 58.23M | 33.11% |
Net income | -54.36M | -37.22% |
Net profit margin | — | — |
Earnings per share | -0.63 | -8.38% |
EBITDA | -57.63M | -33.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 265.71M | 2.48% |
Total assets | 313.44M | 4.20% |
Total liabilities | 55.64M | 23.43% |
Total equity | 257.80M | — |
Shares outstanding | 103.91M | — |
Price to book | 2.87 | — |
Return on assets | -43.53% | — |
Return on capital | -48.63% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -54.36M | -37.22% |
Cash from operations | -44.07M | -49.86% |
Cash from investing | 10.49M | -63.08% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -33.58M | -4,823.90% |
Free cash flow | -21.80M | -22.42% |
About
Founded
2014
Headquarters
Website
Employees
164